TGFB1 and Parkinson disease: It was reported that TGFβ1 and TGFβ2 levels were increased in ventricular cerebrospinal fluid of PD [15], while upregulation of TGFβ1 was associated with dyskinesia caused by long-term L-dopa therapy [16].